Research Article

Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study

Volume: 1 Number: 3 December 31, 2023
EN

Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study

Abstract

Abstract Colorectal cancer (CRC) is one of the most common cancers in the world with high mortality rates, and it is the second leading cause of cancer-related deaths worldwide and it is estimated that more than 930,000 deaths will occur due to CRC. In addition to genetic and environmental factors, oxidative stress, lipid peroxidation and parameter changes in the antioxidant system are among the risk factors. Syringic acid (SA) which contains polyphenolic compounds, has antioxidant, anti-lipid peroxidative and anti-cancer effects. Due to these effects, syringic acid may have a healing effect on HT-29 cells. In our study, we determined the effect of SA on cell viability on HT-29 cells with MTT, and its effects on antioxidant and oxidant parameters with TAC-TOS tests. Syringic acid decreased viability, increased TAC levels and did not cause a significant change in TOS levels in HT-29 cells. These findings may indicate that SA has curative effects on CRC. However, more studies are needed for clinical uses.

Keywords

References

  1. Abaza, M.-S., Al-Attiyah, R. a., Bhardwaj, R., Abbadi, G., Koyippally, M., & Afzal, M. (2013). Syringic acid from Tamarix aucheriana possesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells. Pharmaceutical Biology, 51(9), 1110-1124. https://doi.org/10.3109/13880209.2013.781194
  2. Ahmed, M. (2020). Colon Cancer: A Clinician's Perspective in 2019. Gastroenterology Res, 13(1), 1-10. https://doi.org/10.14740/gr1239
  3. Cikman, O., Soylemez, O., Ozkan, O. F., Kiraz, H. A., Sayar, I., Ademoglu, S., Taysi, S., & Karaayvaz, M. (2015). Antioxidant Activity of Syringic Acid Prevents Oxidative Stress in l-arginine-Induced Acute Pancreatitis: An Experimental Study on Rats. Int Surg, 100(5), 891-896. https://doi.org/10.9738/intsurg-d-14-00170.1
  4. Clemente, S. M., Martínez-Costa, O. H., Monsalve, M., & Samhan-Arias, A. K. (2020). Targeting Lipid Peroxidation for Cancer Treatment. Molecules, 25(21), 5144. https://www.mdpi.com/1420-3049/25/21/5144
  5. Ferah Okkay, I., Okkay, U., Gundogdu, O. L., Bayram, C., Mendil, A. S., Ertugrul, M. S., & Hacimuftuoglu, A. (2022). Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence. Neuroscience Letters, 769, 136385. https://doi.org/https://doi.org/10.1016/j.neulet.2021.136385
  6. Gheena, S., & Ezhilarasan, D. (2019). Syringic acid triggers reactive oxygen species–mediated cytotoxicity in HepG2 cells. Human & Experimental Toxicology, 38(6), 694-702. https://doi.org/10.1177/0960327119839173
  7. Johdi, N. A., & Sukor, N. F. (2020). Colorectal Cancer Immunotherapy: Options and Strategies. Front Immunol, 11, 1624. https://doi.org/10.3389/fimmu.2020.01624
  8. Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J., & Watanabe, T. (2015). Colorectal cancer. Nat Rev Dis Primers, 1, 15065. https://doi.org/10.1038/nrdp.2015.65

Details

Primary Language

English

Subjects

Medical Pharmacology

Journal Section

Research Article

Early Pub Date

December 29, 2023

Publication Date

December 31, 2023

Submission Date

December 11, 2023

Acceptance Date

December 28, 2023

Published in Issue

Year 2023 Volume: 1 Number: 3

APA
Burul, F., Altunlu, Ö., Ferah Okkay, I., Bayram, C., Yesilyurt, F., & Okkay, U. (2023). Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study. Recent Trends in Pharmacology, 1(3), 123-130. https://izlik.org/JA94ZN37LD
AMA
1.Burul F, Altunlu Ö, Ferah Okkay I, Bayram C, Yesilyurt F, Okkay U. Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study. Recent Trends in Pharmacology. 2023;1(3):123-130. https://izlik.org/JA94ZN37LD
Chicago
Burul, Feyza, Öznur Altunlu, Irmak Ferah Okkay, Cemil Bayram, Fatma Yesilyurt, and Ufuk Okkay. 2023. “Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study”. Recent Trends in Pharmacology 1 (3): 123-30. https://izlik.org/JA94ZN37LD.
EndNote
Burul F, Altunlu Ö, Ferah Okkay I, Bayram C, Yesilyurt F, Okkay U (December 1, 2023) Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study. Recent Trends in Pharmacology 1 3 123–130.
IEEE
[1]F. Burul, Ö. Altunlu, I. Ferah Okkay, C. Bayram, F. Yesilyurt, and U. Okkay, “Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study”, Recent Trends in Pharmacology, vol. 1, no. 3, pp. 123–130, Dec. 2023, [Online]. Available: https://izlik.org/JA94ZN37LD
ISNAD
Burul, Feyza - Altunlu, Öznur - Ferah Okkay, Irmak - Bayram, Cemil - Yesilyurt, Fatma - Okkay, Ufuk. “Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study”. Recent Trends in Pharmacology 1/3 (December 1, 2023): 123-130. https://izlik.org/JA94ZN37LD.
JAMA
1.Burul F, Altunlu Ö, Ferah Okkay I, Bayram C, Yesilyurt F, Okkay U. Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study. Recent Trends in Pharmacology. 2023;1:123–130.
MLA
Burul, Feyza, et al. “Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study”. Recent Trends in Pharmacology, vol. 1, no. 3, Dec. 2023, pp. 123-30, https://izlik.org/JA94ZN37LD.
Vancouver
1.Feyza Burul, Öznur Altunlu, Irmak Ferah Okkay, Cemil Bayram, Fatma Yesilyurt, Ufuk Okkay. Investigation of the Antitumoral Activity of Syringic Acid on HT-29 Cells: An In Vitro Study. Recent Trends in Pharmacology [Internet]. 2023 Dec. 1;1(3):123-30. Available from: https://izlik.org/JA94ZN37LD